2016 Q4 Form 10-K Financial Statement

#000117184317001747 Filed on March 24, 2017

View on sec.gov

Income Statement

Concept 2016 Q4 2016 2015 Q4
Revenue $509.0K $3.477M $660.0K
YoY Change -22.88% -39.06% 1.54%
Cost Of Revenue $2.548M $460.0K
YoY Change 3.07% -49.45%
Gross Profit $929.0K $200.0K
YoY Change -71.27% -176.92%
Gross Profit Margin 26.72% 30.3%
Selling, General & Admin $2.520M $8.441M $2.700M
YoY Change -6.67% -17.66% 37.76%
% of Gross Profit 908.61% 1350.0%
Research & Development $3.906M $13.69M $460.0K
YoY Change 749.13% 1266.47% 228.57%
% of Gross Profit 1473.84% 230.0%
Depreciation & Amortization $200.0K $300.0K $40.00K
YoY Change 400.0% 63.04% 33.33%
% of Gross Profit 32.29% 20.0%
Operating Expenses $3.906M $20.46M $3.160M
YoY Change 23.61% 49.1% 50.48%
Operating Profit -$16.99M -$2.960M
YoY Change 51.85% 25.42%
Interest Expense -$60.00K $95.00K -$20.00K
YoY Change 200.0% -32.62%
% of Operating Profit
Other Income/Expense, Net -$60.00K $39.00K
YoY Change -72.34%
Pretax Income -$5.970M -$17.27M -$2.980M
YoY Change 100.34% 52.43% 31.86%
Income Tax
% Of Pretax Income
Net Earnings -$5.974M -$17.27M -$2.980M
YoY Change 100.47% 52.49% 31.86%
Net Earnings / Revenue -1173.67% -496.81% -451.52%
Basic Earnings Per Share
Diluted Earnings Per Share -$149.3M -$431.8M -$59.60M
COMMON SHARES
Basic Shares Outstanding 10.64M
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.10M $22.10M $10.80M
YoY Change 104.63% 104.63% 111.76%
Cash & Equivalents $22.10M $22.10M $21.24M
Short-Term Investments
Other Short-Term Assets $1.800M $1.800M $300.0K
YoY Change 500.0% 500.0% -25.0%
Inventory $64.00K $187.0K
Prepaid Expenses
Receivables $20.00K $0.00 $394.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $23.88M $23.90M $11.73M
YoY Change 103.49% 104.27% 72.94%
LONG-TERM ASSETS
Property, Plant & Equipment $625.0K $600.0K $1.153M
YoY Change -45.79% -50.0% -5.02%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $258.0K $300.0K $0.00
YoY Change -100.0%
Total Long-Term Assets $883.0K $900.0K $1.168M
YoY Change -24.4% -25.0% -10.43%
TOTAL ASSETS
Total Short-Term Assets $23.88M $23.90M $11.73M
Total Long-Term Assets $883.0K $900.0K $1.168M
Total Assets $24.76M $24.80M $12.90M
YoY Change 91.91% 92.25% 59.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.007M $1.000M $242.0K
YoY Change 316.12% 400.0% -5.1%
Accrued Expenses $3.909M $3.900M $1.018M
YoY Change 283.99% 333.33% 181.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $1.100M
YoY Change -100.0% -100.0%
Long-Term Debt Due $2.000M $2.000M $0.00
YoY Change -100.0%
Total Short-Term Liabilities $6.885M $6.900M $2.468M
YoY Change 178.97% 176.0% 24.08%
LONG-TERM LIABILITIES
Long-Term Debt $2.800M $2.800M $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $24.00K
YoY Change -100.0% -77.98%
Total Long-Term Liabilities $0.00 $2.800M $24.00K
YoY Change -100.0% -77.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.885M $6.900M $2.468M
Total Long-Term Liabilities $0.00 $2.800M $24.00K
Total Liabilities $9.705M $9.700M $2.492M
YoY Change 289.45% 288.0% 18.78%
SHAREHOLDERS EQUITY
Retained Earnings -$67.08M -$17.97M
YoY Change 273.31% 170.6%
Common Stock $8.000K $7.000K
YoY Change 14.29% -81.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$61.92M $15.10M -$45.29M
YoY Change
Total Liabilities & Shareholders Equity $24.76M $24.80M $12.90M
YoY Change 91.91% 92.25% 59.5%

Cashflow Statement

Concept 2016 Q4 2016 2015 Q4
OPERATING ACTIVITIES
Net Income -$5.974M -$17.27M -$2.980M
YoY Change 100.47% 52.49% 31.86%
Depreciation, Depletion And Amortization $200.0K $300.0K $40.00K
YoY Change 400.0% 63.04% 33.33%
Cash From Operating Activities -$9.410M -$14.76M -$1.300M
YoY Change 623.85% 113.9% 31.31%
INVESTING ACTIVITIES
Capital Expenditures -$250.0K $250.0K -$20.00K
YoY Change 1150.0% 103.25% -92.59%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$250.0K -$250.0K -$30.00K
YoY Change 733.33% 163.16% -88.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.000K
YoY Change -100.02%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.99M $15.87M 30.00K
YoY Change 53200.0% 24.93% -400.0%
NET CHANGE
Cash From Operating Activities -9.410M -$14.76M -1.300M
Cash From Investing Activities -250.0K -$250.0K -30.00K
Cash From Financing Activities 15.99M $15.87M 30.00K
Net Change In Cash 6.330M $869.0K -1.300M
YoY Change -586.92% -84.79% 3.17%
FREE CASH FLOW
Cash From Operating Activities -$9.410M -$14.76M -$1.300M
Capital Expenditures -$250.0K $250.0K -$20.00K
Free Cash Flow -$9.160M -$15.01M -$1.280M
YoY Change 615.63% 113.72% 77.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 us-gaap Asset Impairment Charges
AssetImpairmentCharges
797000
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
53715
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
64449
CY2015 us-gaap Asset Impairment Charges
AssetImpairmentCharges
CY2016Q4 us-gaap Assets
Assets
4259000
CY2016Q4 mgen Accrued Contract Research And Development
AccruedContractResearchAndDevelopment
203000
CY2015Q4 mgen Accrued Contract Research And Development
AccruedContractResearchAndDevelopment
35000
CY2016Q4 mgen Capital Lease Obligation Unamortized Discount
CapitalLeaseObligationUnamortizedDiscount
3000
CY2015Q4 mgen Capital Lease Obligation Unamortized Discount
CapitalLeaseObligationUnamortizedDiscount
6000
CY2016Q4 mgen Capital Lease Obligations Monthly Rent
CapitalLeaseObligationsMonthlyRent
7200
CY2016Q4 mgen Contractual Allowance
ContractualAllowance
3200000
CY2015Q4 mgen Contractual Allowance
ContractualAllowance
2100000
CY2016 mgen Contractual Allowances
ContractualAllowances
5313000
CY2015 mgen Contractual Allowances
ContractualAllowances
3168000
CY2016 mgen Contractual Allowances Percentage
ContractualAllowancesPercentage
0.61
CY2015 mgen Contractual Allowances Percentage
ContractualAllowancesPercentage
0.56
CY2016 mgen Effective Income Tax Rate Reconciliation Credits And Other Adjustments
EffectiveIncomeTaxRateReconciliationCreditsAndOtherAdjustments
331000
CY2015 mgen Effective Income Tax Rate Reconciliation Credits And Other Adjustments
EffectiveIncomeTaxRateReconciliationCreditsAndOtherAdjustments
-42000
CY2016 mgen Increase Decrease In Lease Termination Abandonment Payable
IncreaseDecreaseInLeaseTerminationAbandonmentPayable
CY2015 mgen Increase Decrease In Lease Termination Abandonment Payable
IncreaseDecreaseInLeaseTerminationAbandonmentPayable
248000
CY2016 mgen Sales Revenue Gross
SalesRevenueGross
8650000
CY2015 mgen Sales Revenue Gross
SalesRevenueGross
5706000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
159000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
242000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
524000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
394000
CY2016Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
860000
CY2015Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
592000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3377000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1018000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
739000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30309000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
28371000
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
8700000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3015000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2111000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2111000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3015000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
54000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2015 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
5713000
CY2016Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
80.70
CY2015Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
52.50
CY2015Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
10707
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13534
CY2015Q4 us-gaap Assets
Assets
12902000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
4259000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
11734000
CY2016Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
170000
CY2015Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
CY2016 us-gaap Business Exit Costs1
BusinessExitCosts1
2037000
CY2015 us-gaap Business Exit Costs1
BusinessExitCosts1
CY2016Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
4000
CY2015Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
88000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3341000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10832000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5119000
CY2016 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-7491000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
118694
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
742293
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
709024
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
742293
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
709024
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
7000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
7000
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Concentration of Credit Risk, Major Customers and Suppliers</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Financial instruments that potentially subject Signal to concentrations of credit risk are primarily cash and cash equivalents. Cash is maintained at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> financial institutions and, at times, balances <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> exceed federally insured limits. Signal has not experienced any losses related to these balances. Signal invests excess cash in money market funds under the custodianship of a major financial institution. This diversification of risk is consistent with Signal&#x2019;s policy to ensure safety of principal and maintain liquidity.</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> Signal had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> major customers, including UAMS. Revenue sourced either from or through UAMS accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">54%</div> of net revenue during the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> respectively. Revenue sourced either from or through Mount Sinai Hospital as a percentage of net revenue during the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%,</div> respectively. Revenue sourced either from or through Moffitt Cancer Center as a percentage of net revenue during the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9%,</div> respectively.</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Accounts receivable from UAMS as a percentage of total accounts receivable as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19%,</div> respectively. Signal had no accounts receivable from the other <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> major customers since revenue sourced through them is billed to various <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div>-party payors, depending on a patient&#x2019;s medical insurance policy.</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Inventory used in Signal&#x2019;s testing process is procured from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> supplier. Any supply interruption or an increase in demand beyond such supplier&#x2019;s capabilities could have an adverse impact on Signal&#x2019;s business. Management believes it could identify alternative suppliers, if necessary, but it is possible such suppliers <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> not be identified in a timely manner to avoid an adverse impact on Signal&#x2019;s business.</div></div></div>
CY2016 us-gaap Cost Of Revenue
CostOfRevenue
2548000
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
2472000
CY2016 us-gaap Costs And Expenses
CostsAndExpenses
15845000
CY2015 us-gaap Costs And Expenses
CostsAndExpenses
13725000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
7792000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5046000
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
10000
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
350000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6883000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3913000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
52000
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
98000
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
52000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
505000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
257000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
205000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
810000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
49000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
14000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7782000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4696000
CY2016Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
10000
CY2015Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
350000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
189000
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
184000
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-17.58
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-21.02
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
125000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
234000
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-71000
CY2015 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7906000
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7692000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3086000
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3625000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4309000
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3851000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
364000
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
19000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
721000
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
526000
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-193000
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-277000
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2028000
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
633000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
130000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-694000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2468000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-257000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12706000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-95000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7231000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6898000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-12674000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-11328000
CY2016 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
CY2015 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
28000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-123000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-161000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-28000
CY2016 us-gaap Interest Expense
InterestExpense
95000
CY2015 us-gaap Interest Expense
InterestExpense
141000
CY2016 us-gaap Interest Paid
InterestPaid
2000
CY2015 us-gaap Interest Paid
InterestPaid
6000
CY2016Q4 us-gaap Inventory Net
InventoryNet
64000
CY2015Q4 us-gaap Inventory Net
InventoryNet
187000
CY2015Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
198000
CY2015 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
330000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4259000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12902000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4585000
CY2016Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
1045000
CY2015Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
1105000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-12508000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-11187000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
240000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
234000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
148000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
84000
CY2016 us-gaap Other Expenses
OtherExpenses
166000
CY2015 us-gaap Other Expenses
OtherExpenses
141000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
103000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
24000
CY2016 us-gaap Paid In Kind Interest
PaidInKindInterest
93000
CY2015 us-gaap Paid In Kind Interest
PaidInKindInterest
132000
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2000
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2016 us-gaap Payments For Restructuring
PaymentsForRestructuring
292000
CY2015Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1200000
CY2016 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
171000
CY2015 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
363000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
123000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
160000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
321000
CY2015Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7800000
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13095000
CY2016 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
CY2015 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
50000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1892000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1153000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
74000
CY2015 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
33000
CY2016 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
84000
CY2015 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
76000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
888000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1002000
CY2015 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-363000
CY2016 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-171000
CY2016Q4 us-gaap Restructuring Reserve
RestructuringReserve
1745000
CY2016Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1745000
CY2015Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30642000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17968000
CY2016 us-gaap Royalty Expense
RoyaltyExpense
86000
CY2015 us-gaap Royalty Expense
RoyaltyExpense
30000
CY2016Q4 us-gaap Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
30000
CY2016 us-gaap Sales Revenue Net
SalesRevenueNet
3337000
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
2538000
CY2016Q4 us-gaap Security Deposit
SecurityDeposit
CY2015Q4 us-gaap Security Deposit
SecurityDeposit
15000
CY2016 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1669000
CY2015 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2559000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
2111000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
3015000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
67695
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
37465
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
28.83
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
10425
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5786
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
37465
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
42104
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
34.20
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
28.83
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
37465
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
28.83
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
38.83
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.71
CY2015Q1 us-gaap Share Price
SharePrice
42
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y219D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y219D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y219D
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
214286
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12765000
CY2016 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-326000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
10410000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
5991000
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;). The preparation of financial statements in conformity with GAAP requires management to make judgments, assumptions and estimates that affect the amounts reported in Signal&#x2019;s financial statements and accompanying notes. Significant estimates in the financial statements have been made for revenue, accounts receivable and allowance for doubtful accounts, accounting for income taxes, depreciation of property and equipment and stock-based compensation. Actual results could differ materially from those estimates.</div></div></div>
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
721415
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
539460

Files In Submission

Name View Source Status
0001171843-17-001747-index-headers.html Edgar Link pending
0001171843-17-001747-index.html Edgar Link pending
0001171843-17-001747.txt Edgar Link pending
0001171843-17-001747-xbrl.zip Edgar Link pending
exh_211.htm Edgar Link pending
exh_231.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
f10k_032417p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mgen-20161231.xml Edgar Link completed
mgen-20161231.xsd Edgar Link pending
mgen-20161231_cal.xml Edgar Link unprocessable
mgen-20161231_def.xml Edgar Link unprocessable
mgen-20161231_lab.xml Edgar Link unprocessable
mgen-20161231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending